Dr. Stansfield has also held senior management positions at Quintiles and Innovex, where she was responsible for business process improvement and managing full-service clinical research projects. Dr. Stansfield began her career in clinical research in various positions with the Wellcome Research Foundation, the Janssen Research Foundation, and Parke Davis.
Dr. Stansfield has a BSc in Physiology and Biochemistry from Nottingham University and a PhD in Neuropharmacology from Reading University.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that are subject
to risks and uncertainties relating to PRA International's future financial
and business performance, as well as any other predictive statements that
depend on future events or conditions, or that include words such as
"expect," "anticipate," "intend," "plan," "believe," "seek," "may," "will,"
"estimate" or similar expressions of futurity. You should not place undue
reliance on any forward-looking statements, which represent the company's
statements only as of the date of this news release and are not intended to
give any assurance as to actual future events. Factors that might cause
future events to differ include: operational and personnel challenges that
could result from management changes; the ability to execute our strategy
during management transitions; the ongoing need for early and late phase
drug development services; project cancellations and timing issues; our
ability to attract and retain qualified personnel; our ability to continue
providing our services effectively, including the quality or accuracy of
the data or reports provided and our ability to meet agreed-upon schedules;
the ability and willingness of our clients to continue to spend on research
a
'/>"/>
| SOURCE PRA International Copyright©2007 PR Newswire. All rights reserved |